Compared to other medications (i.e., insulin, thiazolidinediones, SGLT2 inhibitors, and sulfonylurea), metformin demonstrated significantly improved outcomes in any diabetes-related endpoint, all-cause mortality, and stroke. Here, INS is linked to diabetes mellitus.